1. Foldi CJ (2024). Taking better advantage of the activity-based anorexia model. Trends in Molecular Medicine. 30 (4), 330-338.
2. Reed F & Foldi CJ (2024). Do the therapeutic effects of psilocybin involve actions in the gut? Trends in Pharmacological Sciences, 45 (2), 107-117.
3. Conn K*, Milton LK*, Huang K, Munguba H, Ruuska J, Lemus MB, Greaves E, Homman-Ludiye J, Oldfield BH & Foldi CJ (2024). Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms. Molecular Psychiatry Apr 27.
4. Milton LK, Mirabella PN, Greaves E, Spanswick DC, van den Buuse M, Oldfield BJ, Foldi CJ (2021). Suppression of Corticostriatal Circuit Activity Improves Cognitive Flexibility and Prevents Body Weight Loss in Activity-Based Anorexia in Rats. Biological Psychiatry,90(12):819-828
5. Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ (2020). Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models. Frontiers in Neuroscience, 4;14:43
A full list of Foldi Lab publications can be viewed on PubMed.